193 related articles for article (PubMed ID: 23222296)
1. Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma.
Lau JK; Brown KC; Thornhill BA; Crabtree CM; Dom AM; Witte TR; Hardman WE; McNees CA; Stover CA; Carpenter AB; Luo H; Chen YC; Shiflett BS; Dasgupta P
Cancer Res; 2013 Feb; 73(4):1328-39. PubMed ID: 23222296
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma.
Song P; Sekhon HS; Jia Y; Keller JA; Blusztajn JK; Mark GP; Spindel ER
Cancer Res; 2003 Jan; 63(1):214-21. PubMed ID: 12517800
[TBL] [Abstract][Full Text] [Related]
3. Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
Song P; Sekhon HS; Fu XW; Maier M; Jia Y; Duan J; Proskosil BJ; Gravett C; Lindstrom J; Mark GP; Saha S; Spindel ER
Cancer Res; 2008 Jun; 68(12):4693-700. PubMed ID: 18559515
[TBL] [Abstract][Full Text] [Related]
4. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).
Roghani A; Carroll PT
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):21-30. PubMed ID: 12008018
[TBL] [Abstract][Full Text] [Related]
5. Evoked acetylcholine release by immortalized brain endothelial cells genetically modified to express choline acetyltransferase and/or the vesicular acetylcholine transporter.
Malo M; Diebler MF; Prado de Carvalho L; Meunier FM; Dunant Y; Bloc A; Stinnakre J; Tomasi M; Tchélingérian J; Couraud PO; Israël M
J Neurochem; 1999 Oct; 73(4):1483-91. PubMed ID: 10501193
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy.
Inazu M; Yamada T; Kubota N; Yamanaka T
Pharmacol Res; 2013 Oct; 76():119-31. PubMed ID: 23948665
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 Regulates the Cholinergic Locus and CHT1 Through Akt Signaling Pathway.
Yan J; Zhao W; Guo M; Han X; Feng Z
Cell Physiol Biochem; 2016; 40(5):982-992. PubMed ID: 27941337
[TBL] [Abstract][Full Text] [Related]
8. The cholinergic system in rat testis is of non-neuronal origin.
Schirmer SU; Eckhardt I; Lau H; Klein J; DeGraaf YC; Lips KS; Pineau C; Gibbins IL; Kummer W; Meinhardt A; Haberberger RV
Reproduction; 2011 Jul; 142(1):157-66. PubMed ID: 21482687
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic administration of 2-(4-phenyl-piperidino)-cyclohexanol (vesamicol) and an organophosphate DDVP on the cholinergic system in brain regions of rats.
Kobayashi H; Watanabe T; Yasufuku T; Suzuki T; Saitoh S; Takeno K
Brain Res Bull; 1997; 43(1):17-23. PubMed ID: 9205789
[TBL] [Abstract][Full Text] [Related]
10. Search for the acetylcholine and vesamicol binding sites in vesicular acetylcholine transporter: the region around the lumenal end of the transport channel.
Khare P; Mulakaluri A; Parsons SM
J Neurochem; 2010 Nov; 115(4):984-93. PubMed ID: 20831599
[TBL] [Abstract][Full Text] [Related]
11. Active transport of acetylcholine by the human vesicular acetylcholine transporter.
Varoqui H; Erickson JD
J Biol Chem; 1996 Nov; 271(44):27229-32. PubMed ID: 8910293
[TBL] [Abstract][Full Text] [Related]
12. Regulation of vesicular acetylcholine transporter by the activation of excitatory amino acid receptors in the avian retina.
Loureiro-dos-Santos NE; Prado MA; Reis RA; Gardino PF; de Mello MC; de Mello FG
Cell Mol Neurobiol; 2002 Dec; 22(5-6):727-40. PubMed ID: 12585691
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications.
Saw EL; Pearson JT; Schwenke DO; Munasinghe PE; Tsuchimochi H; Rawal S; Coffey S; Davis P; Bunton R; Van Hout I; Kai Y; Williams MJA; Kakinuma Y; Fronius M; Katare R
Cardiovasc Diabetol; 2021 Feb; 20(1):50. PubMed ID: 33618724
[TBL] [Abstract][Full Text] [Related]
14. Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol.
Khare P; White AR; Parsons SM
Biochemistry; 2009 Sep; 48(38):8965-75. PubMed ID: 19685929
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
Prior C; Marshall IG; Parsons SM
Gen Pharmacol; 1992 Nov; 23(6):1017-22. PubMed ID: 1487110
[TBL] [Abstract][Full Text] [Related]
16. Effect of protein kinase C activation on the release of [3H]acetylcholine in the presence of vesamicol.
Barbosa J; Clarizia AD; Gomez MV; Romano-Silva MA; Prado VF; Prado MA
J Neurochem; 1997 Dec; 69(6):2608-11. PubMed ID: 9375695
[TBL] [Abstract][Full Text] [Related]
17. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
18. Possible important pair of acidic residues in vesicular acetylcholine transporter.
Khare P; Ojeda AM; Chandrasekaran A; Parsons SM
Biochemistry; 2010 Apr; 49(14):3049-59. PubMed ID: 20225888
[TBL] [Abstract][Full Text] [Related]
19. Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions.
Roy A; Dakroub M; Tezini GC; Liu Y; Guatimosim S; Feng Q; Salgado HC; Prado VF; Prado MA; Gros R
FASEB J; 2016 Feb; 30(2):688-701. PubMed ID: 26481308
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons.
Auld DS; Mennicken F; Day JC; Quirion R
J Neurochem; 2001 Apr; 77(1):253-62. PubMed ID: 11279281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
